Topical lidocaine and epidural bupivacaine/hydromorphone in the treatment of complex regional pain syndrome type 2.
Vorobeychik
Yakov
Y
Giampetro
David M
DM
D000287:Administration, Topical; D000328:Adult; D015360:Analgesia, Epidural / Q000379:methods; D000701:Analgesics, Opioid / Q000008:administration & dosage; D000779:Anesthetics, Local / Q000008:administration & dosage; D002045:Bupivacaine / Q000008:administration & dosage*; D002422:Causalgia / Q000188:drug therapy* / Q000503:physiopathology; D002813:Chondrosarcoma / Q000473:pathology / Q000601:surgery; D004338:Drug Combinations; D004357:Drug Synergism; D005260:Female; D006801:Humans; D004091:Hydromorphone / Q000008:administration & dosage*; D007866:Leg / Q000294:innervation / Q000503:physiopathology; D008012:Lidocaine / Q000008:administration & dosage*; D010098:Oxycodone / Q000627:therapeutic use; D000069583:Pregabalin; D012447:Sacrum / Q000473:pathology / Q000601:surgery; D013126:Spinal Nerve Roots / Q000293:injuries / Q000503:physiopathology; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D004338:Drug Combinations; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D008012:Lidocaine; D010098:Oxycodone; D004091:Hydromorphone; D002045:Bupivacaine